NANBIOSIS: Production and Characterization of Nanomaterials, Biomaterials and Biomedical Systems - Drug Formulation Platform

Áreas de investigación
  • Life & Medical Sciences

José Luis Pedraz Muñoz (Head of Platform)

¿Disponible para usuarios externos?
Protocolo de acceso

Please check website


The CIBER-BBN Research Infrastructure in Biomedicine is constituted as clusters of existing technical-scientific equipment which complement or are complemented by that equipment provided by CIBER-BBN. These clusters offer toplevel technological resources to the CIBER-BBN research groups, external groups and companies, under established conditions.

This Infrastructure includes 24 Units which are distributed through the Spanish geography. Its Drug Formulation Platform is located at University of the Basque Country.

  • Design and development of:
    - Classic parenteral dosage forms
    - Parenteral dosage forms for sustained release
    - Classic oral dosage forms
    - Oral dosage forms for sustained release
  • Design and development of micro and nanocapsules for conventional drugs
  • Design and development of micro and nanocapsules for peptides and proteins
  • Design and development of solid lipid nanoparticles-based non-viral vectors
  • Design and development of scaffolds for cell inmobilisation
  • Biopharmaceutical evaluation of dosage forms, quality assurance and stability studies
  • Setup and validation of analytical techniques for the quantification of drugs, metabolites, degradation degradation products and impurities
  • Pharmacokinetic pre-clinical studies of new molecules (pre-clinical pharmacokinetics)

NanoBioCel Group - Laboratory of Pharmacy and Pharmaceutical Technology
Faculty of Farmacy
University of the Basque Country (UPV/EHU)
C/Paseo de la Universidad, 7
01006 Vitoria-Gasteiz (Alava)